| 1 |
33771885 | Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer. | 2021 Jun |
2 |
| 2 |
33989112 | Protein kinase inhibitors for the treatment of prostate cancer. | 2021 Oct |
2 |
| 3 |
34493147 | Inside prostate cancer news from the 2021 ASCO Genitourinary Cancers Symposium. | 2021 Nov |
1 |
| 4 |
31705765 | Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer. | 2020 Apr |
1 |
| 5 |
30206162 | Precision Medicine Approaches When Prostate Cancer Akts Up. | 2019 Feb 1 |
1 |
| 6 |
29911685 | Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. | 2018 May |
2 |
| 7 |
28411207 | Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer. | 2017 Jul |
1 |
| 8 |
25454616 | PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate. | 2015 Apr |
2 |